Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Citigroup Initiates Coverage On Genpact with Neutral Rating, Announces Price Target of $43

Author: Benzinga Newsdesk | October 22, 2025 05:34pm
Citigroup analyst Bryan Keane initiates coverage on Genpact (NYSE:G) with a Neutral rating and announces Price Target of $43.

Posted In: G

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist